1. Home
  2. SANA vs ALRS Comparison

SANA vs ALRS Comparison

Compare SANA & ALRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SANA
  • ALRS
  • Stock Information
  • Founded
  • SANA 2018
  • ALRS 1879
  • Country
  • SANA United States
  • ALRS United States
  • Employees
  • SANA N/A
  • ALRS N/A
  • Industry
  • SANA Medicinal Chemicals and Botanical Products
  • ALRS Major Banks
  • Sector
  • SANA Health Care
  • ALRS Finance
  • Exchange
  • SANA Nasdaq
  • ALRS Nasdaq
  • Market Cap
  • SANA 522.4M
  • ALRS 488.5M
  • IPO Year
  • SANA 2021
  • ALRS 2019
  • Fundamental
  • Price
  • SANA $2.92
  • ALRS $20.29
  • Analyst Decision
  • SANA Strong Buy
  • ALRS Hold
  • Analyst Count
  • SANA 4
  • ALRS 4
  • Target Price
  • SANA $13.00
  • ALRS $23.25
  • AVG Volume (30 Days)
  • SANA 14.7M
  • ALRS 103.4K
  • Earning Date
  • SANA 02-27-2025
  • ALRS 01-31-2025
  • Dividend Yield
  • SANA N/A
  • ALRS 3.92%
  • EPS Growth
  • SANA N/A
  • ALRS N/A
  • EPS
  • SANA N/A
  • ALRS 0.16
  • Revenue
  • SANA N/A
  • ALRS $164,503,000.00
  • Revenue This Year
  • SANA N/A
  • ALRS N/A
  • Revenue Next Year
  • SANA N/A
  • ALRS $26.79
  • P/E Ratio
  • SANA N/A
  • ALRS $125.27
  • Revenue Growth
  • SANA N/A
  • ALRS N/A
  • 52 Week Low
  • SANA $1.52
  • ALRS $17.99
  • 52 Week High
  • SANA $12.00
  • ALRS $25.85
  • Technical
  • Relative Strength Index (RSI)
  • SANA 53.45
  • ALRS 55.20
  • Support Level
  • SANA $3.05
  • ALRS $19.29
  • Resistance Level
  • SANA $3.86
  • ALRS $19.09
  • Average True Range (ATR)
  • SANA 0.66
  • ALRS 0.46
  • MACD
  • SANA 0.12
  • ALRS 0.20
  • Stochastic Oscillator
  • SANA 24.22
  • ALRS 90.55

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.

About ALRS Alerus Financial Corporation

Alerus Financial Corp is a financial holding company registered in the United States. The company operates in four segments: Banking, Retirement & Benefit Services, Wealth Management, and Mortgage. It provides various banking services such as checking, debit cards, savings, current deposits, loans and advances, online banking, mobile banking, private banking, payment solutions, and other business products. Additionally, the company provides mortgage loans, retirement planning solutions, individual retirement accounts, retirement plan advisory services as well as wealth management services, including financial & estate planning, trust, and fiduciary services. The company's revenue mainly consists of interest income, commission, management fees, and other income.

Share on Social Networks: